Evidence map›Paper›PMID 30567412›Full record

ArticleCells2018

Activation of Polyamine Catabolism by N¹,N

Olga N Ivanova, Anastasiya V Snezhkina, George S Krasnov, Vladimir T Valuev-Elliston, Olga A Khomich, Alexey R Khomutov, Tuomo A Keinanen, Leena Alhonen, Birke Bartosch, Anna V Kudryavtseva and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Olga N IvanovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia. olgaum@yandex.ru.
Anastasiya V SnezhkinaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia. leftger@rambler.ru.
George S KrasnovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia. gskrasnov@mail.ru.
Vladimir T Valuev-EllistonEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia. gansfaust@mail.ru.
Olga A KhomichEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia. oakhomich@gmail.com.
Alexey R KhomutovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia. alexkhom@list.ru.
Tuomo A KeinanenSchool of Pharmacy, Biocenter Kuopio, University of Eastern Finland, FI-70211 Kuopio, Finland. tuomo.keinanen@uef.fi.ORCID 0000-0002-0659-5573
Leena AlhonenSchool of Pharmacy, Biocenter Kuopio, University of Eastern Finland, FI-70211 Kuopio, Finland. alhonenl@gmail.com.
Birke BartoschCancer Research Center Lyon, INSERM U1052 and CNRS 5286, Lyon University, 69000 Lyon, France. birke.bartosch@inserm.fr.ORCID 0000-0001-6354-4660
Anna V KudryavtsevaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia. rhizamoeba@mail.ru.ORCID 0000-0002-3722-8207
Sergey N KochetkovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia. kochet@eimb.ru.
Alexander V IvanovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia. aivanov@yandex.ru.ORCID 0000-0002-5659-9679
Engelhardt Institute of Molecular Biology · RUUniversity of Eastern Finland · FICentre National de la Recherche Scientifique · FR

Funding

Comité de Saône-et-Loire de la Ligue contre le cancer, Agence Nationale de Recherche, the Region Rhone-Alpes NADevWeCan French Laboratories of Excellence Network ANR-10-LABX-61French National Agency for AIDS and Viral Hepatitis Research 14370OpeRa IHU program ANR-10-IBHU-004Russian Science Foundation 14-14-01021University of Eastern Finland NA
6 · The paper itself

Abstract

Tumorigenesis is accompanied by the metabolic adaptation of cells to support enhanced proliferation rates and to optimize tumor persistence and amplification within the local microenvironment. In particular, cancer cells exhibit elevated levels of biogenic polyamines. Inhibitors of polyamine biosynthesis and inducers of their catabolism have been evaluated as antitumor drugs, however, their efficacy and safety remain controversial. Our goal was to investigate if drug-induced modulation of polyamine metabolism plays a role in dedifferentiation using differentiated human hepatocyte-like HepaRG cell cultures. N¹,N

Indexed as

dedifferentiationEMTHepaRGhepatocytesNextSeqpolyamine analoguespolyamine catabolismpolyaminesspermidine

Identifiers

PMID30567412
PMCPMC6316793
OpenAlexW2904795227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.